Literature DB >> 16338621

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities.

Christopher J Schwake1, Mary Eapen, Stephanie J Lee, César O Freytes, Sergio A Giralt, Willis H Navarro, J Douglas Rizzo, Koen van Besien, Fausto R Loberiza.   

Abstract

Racial or ethnic minorities with leukemia who receive HLA-identical sibling hematopoietic stem cell transplants (HSCTs) are reported to have worse survival when compared with whites. Characteristics of US HSCT centers according to the proportion of ethnic minorities who undergo transplantation were compared to explore systematic differences among centers; the association with 100-day mortality was evaluated to determine whether center factors may explain the observed discrepant survival among ethnic minorities. One hundred sixteen US transplantation centers that performed HLA-identical sibling transplantations for leukemia were analyzed. We compared physician and health care provider staffing, transplantation unit procedure and resources, and medical center organization according to the volume procedure ratio of ethnic minorities who underwent transplantation and also according to the ratio of Hispanics who underwent transplantation. Centers that performed transplantation in a higher proportion of ethnic minorities were more likely to perform fewer transplantations per year, to have fewer devoted transplant beds, to be in an urban setting, to have a lower physician to patient volume ratio, and to follow up survivors 1 year after transplantation. Centers that performed transplantation in a higher proportion of Hispanics were more likely to perform fewer transplantations per year and to have fewer devoted transplantation beds, were less likely to perform outpatient transplantations, were more likely to be in an urban setting, and were less likely to have posttransplantation immunization protocols. Observed differences in center factors were not associated with 100-day mortality after adjustment for disease severity. Our results suggest that the inferior survival reported in ethnic minorities after HSCT may not be readily explained by center effects.

Entities:  

Mesh:

Year:  2005        PMID: 16338621     DOI: 10.1016/j.bbmt.2005.07.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  9 in total

1.  Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

Authors:  Koen van Besien; Parameswaran Hari; Mei-Jie Zhang; Hong-Tao Liu; Wendy Stock; Lucy Godley; Olatoyosi Odenike; Richard Larson; Michael Bishop; Amittha Wickrema; Usama Gergis; Sebastian Mayer; Tsiporah Shore; Stephanie Tsai; Joanna Rhodes; Melissa M Cushing; Sandra Korman; Andrew Artz
Journal:  Haematologica       Date:  2016-02-11       Impact factor: 9.941

2.  Factors associated with self-reported physical and mental health after hematopoietic cell transplantation.

Authors:  John R Wingard; I-Chan Huang; Kathleen A Sobocinski; Michael A Andrykowski; David Cella; J Douglas Rizzo; Marianne Brady; Mary M Horowitz; Michelle M Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-01       Impact factor: 5.742

Review 3.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.

Authors:  Steven Z Pavletic; Shaji Kumar; Mohamad Mohty; Marcos de Lima; James M Foran; Marcelo Pasquini; Mei-Jie Zhang; Sergio Giralt; Michael R Bishop; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

4.  Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites.

Authors:  B K Hamilton; L Rybicki; M Sekeres; M Kalaycio; R Hanna; R Sobecks; R Dean; H Duong; B T Hill; B Bolwell; E Copelan
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

Review 5.  Racial disparities in hematopoietic stem cell transplant: a systematic review of the literature.

Authors:  Ian Landry
Journal:  Stem Cell Investig       Date:  2021-12-14

Review 6.  What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?

Authors:  Claudio Anasetti
Journal:  Best Pract Res Clin Haematol       Date:  2008-12       Impact factor: 3.020

7.  Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.

Authors:  Fausto R Loberiza; Stephanie J Lee; Cesar O Freytes; Sergio A Giralt; Koen Van Besien; Seira Kurian; Paula del Cerro; Juan J Toro; Loretta A Williams; Seth W Ketelsen; Willis H Navarro; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2009-08       Impact factor: 5.742

Review 8.  Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Authors:  Mateja Kralj Juric; Sakhila Ghimire; Justyna Ogonek; Eva M Weissinger; Ernst Holler; Jon J van Rood; Machteld Oudshoorn; Anne Dickinson; Hildegard T Greinix
Journal:  Front Immunol       Date:  2016-11-09       Impact factor: 7.561

9.  Parental limited English proficiency in pediatric stem cell transplantation: Clinical impact and health care utilization.

Authors:  Joanna M Robles; Jesse D Troy; Kristin M Schroeder; Paul L Martin; Thomas W LeBlanc
Journal:  Pediatr Blood Cancer       Date:  2021-06-09       Impact factor: 3.838

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.